In the early 2000s, the five intrinsic molecular subtypes of breast cancer (luminal A, luminal B, basal-like, Erb-B2/HER2-enriched, and normal breast-like) were first described, separated by gene expression analysis and with different biological properties and outcomes [8, 9]. Here, ERBB2 is linked to breast cancer.